SCHEMBL766967

SCHEMBL766967

C=CCCCOC(=O)OCCCC=C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
TSHR P16473 4/20 0.44
CYP3A4 P08684 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 3/20 0.43
ABCC4 O15439 1/20 0.43
LPAR3 Q9UBY5 2/20 0.42
LMNA P02545 2/20 0.42
LPAR2 Q9HBW0 1/20 0.42
HPGD P15428 2/20 0.40
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ATM Q13315 1/20 0.38
USP2 O75604 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RECQL P46063 1/20 0.37
HRH4 Q9H3N8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
TP53 P04637 1/20 0.34
HIF1A Q16665 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5914608 0.93 LPAR3 (0.50) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL9181867 0.91 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL11522576 0.91 ALDH1A1 (0.40) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL10991327 0.91 LPAR3 (0.53) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL6951113 0.91 LPAR3 (0.53) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL24131355 0.89 ALDH1A1 (0.39) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL47886 0.87 CA2 (0.42) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL27101973 0.86 TSHR (0.50) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL9246275 0.85 ALDH1A1 (0.44) ALDH1A1TSHRCYP3A4L3MBTL1MAPT
SCHEMBL6707404 0.83 TSHR (0.55) ALDH1A1TSHRCYP3A4MAPTLPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4062475-B1 ELECTROLYTE BASED ON A LITHIUM SALT ARKEMA FRANCE (FR) 2023-08-23 EP claimed
US-20220166066-A1 ELECTROLYTE COMPOSITION CONTAINING A MIXTURE OF LITHIUM SALTS ARKEMA FRANCE (FR) 2022-05-26 US claimed
CN-113826255-A Electrolyte composition containing a mixture of lithium salts 阿科玛法国公司 2021-12-21 CN claimed
CN-110998950-A Lithium salt mixtures and their use as battery electrolytes 阿科玛法国公司 2020-04-10 CN claimed
CN-109478680-A For lithium-sulfur cell based on sulfide/polysulfide il electrolyte 希德泰克基金会 2019-03-15 CN claimed
US-4463127-A Crosslinkable graft polymer dispersion of organopolysiloxanes containing hydrogen-siloxane groups and Si-vinyl groups BAYER AKTIENGESELLSCHAFT (DE) 1984-07-31 US claimed
US-20260128390-A1 Energy Storage Cell, Energy Storage Device, Motor Vehicle, and Method for Producing an Energy Storage Cell BAYERISCHE MOTOREN WERKE AG (DE) 2026-05-07 US disclosed
CN-119695121-A Silicon carbon material and secondary battery comprising same 湖南中科星城石墨有限公司 2025-03-25 CN disclosed
CN-110692158-B Alkali metal-sulfur secondary battery containing polymer-encapsulated sulfur cathode and method of manufacture 纳米技术仪器公司 2024-03-08 CN disclosed
CN-117352848-A Lithium metal battery electrolyte, preparation method thereof and lithium metal battery 北京金羽新材科技有限公司 2024-01-05 CN disclosed
US-11848446-B2 Anode-free rechargeable lithium battery including transition metal dichalcogenide layer and method of manufacturing same KOREA UNIVERSITY OF TECHNOLOGY AND EDUCATION INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2023-12-19 US disclosed
WO-2023234060-A1 OIL-RESISTANT AGENT COMPOSITION AND OIL-RESISTANT PRODUCT 明成化学工業株式会社 2023-12-07 WO disclosed
CN-110612631-B Alkali metal-sulfur secondary battery containing protected sulfur cathode and method of manufacture 纳米技术仪器公司 2023-10-24 CN disclosed
WO-2006051888-A1 COMPOSITE SEMIPERMEABLE MEMBRANE, PRODUCTION PROCESS THEREOF, AND ELEMENT, FLUID SEPARATION EQUIPMENT AND TREATMENT METHOD FOR BORON-CONTAINING WATER USING THE SAME TORAY INDUSTRIES, INC. (JP) 2006-05-18 WO disclosed
US-4792560-A ANTIALLERGENS; ANTIINFLAMMATORY AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1988-12-20 US disclosed
EP-0196674-A2 Hydroxamates as modulators of arachidonic acid metabolic pathways USV PHARMACEUTICAL CORPORATION (US) 1986-10-08 EP disclosed
US-4469840-A FINISHING TEXTILES BAYER AKTIENGESELLSCHAFT (DE) 1984-09-04 US disclosed
US-4464506-A COPOLYMER OF VINYL ORGANOSILOXANE, SI-H GROUP ORGANOSILOXANE, AND ADDITIONAL MONOMER BAYER AKTIENGESELLSCHAFT (DE) 1984-08-07 US disclosed
US-4463127-A Crosslinkable graft polymer dispersion of organopolysiloxanes containing hydrogen-siloxane groups and Si-vinyl groups BAYER AKTIENGESELLSCHAFT (DE) 1984-07-31 US disclosed
US-4217298-A Process for preparing organic carbonates TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1980-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260128390-A1 Energy Storage Cell, Energy Storage Device, Motor Vehicle, and Method for Producing an Energy Storage Cell ILK, DCX, SMN1; SMN2 ALDH1A1 1963/4885TSHR 2317/4885CYP3A4 4667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.